Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch | PRODUCT CODE: 1465998

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1465998

Blood Glucose Monitoring Market by Product, Testing Technology, Application, Distribution Channel, End-User - Global Forecast 2024-2030

PUBLISHED:
PAGES: 194 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF, Excel & Online Access - 1 Year (Up to 5 User License)
USD 4949
PDF, Excel & Online Access - 1 Year (Enterprise User License)
USD 6969

Add to Cart

[194 Pages Report] The Blood Glucose Monitoring Market size was estimated at USD 13.06 billion in 2023 and expected to reach USD 14.08 billion in 2024, at a CAGR 8.28% to reach USD 22.80 billion by 2030.

Blood glucose monitoring refers to the ongoing process of tracking the levels of glucose in the bloodstream, which is crucial for individuals managing diabetes. This practice helps in making informed decisions regarding diet, exercise, and medication, contributing to the effective management of blood sugar levels and reducing the risk of diabetes-related complications. The expansion of its use is primarily driven by the growing prevalence of diabetes globally, advancements in technology that provide more convenient and less invasive monitoring options, increased awareness about the importance of glycemic control, and the development of integrated care models. However, discomfort and pain related to frequent finger-prick tests, the cost of monitoring supplies, and the potential for inaccurate readings due to user error or device malfunction impact the product adoption. Manufacturers are focusing on developing continuous glucose monitors (CGMs) that offer painless, real-time monitoring while reducing user involvement, as well as investing in smart devices that can integrate with mobile technology for enhanced data tracking and analysis. The future opportunities in blood glucose monitoring are abundant, with prospects of non-invasive techniques, artificial intelligence (AI) for predictive analytics, and interconnected healthcare devices that could contribute to a more personalized and efficient diabetes management landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 13.06 billion
Estimated Year [2024] USD 14.08 billion
Forecast Year [2030] USD 22.80 billion
CAGR (%) 8.28%

Product: Provision of personalized guidance in self-monitoring blood glucose monitors

Continuous blood glucose monitors are ideal for patients who require real-time glucose monitoring, particularly those with Type 1 diabetes or those who have intensive insulin therapy needs. CGMs are prescribed for users who benefit from tracking trends in glucose levels throughout the day, enabling more precise insulin dosing and better overall glucose management. Compared to self-monitoring blood glucose (SMBG) devices, CGMs offer the advantage of providing continuous, dynamic glucose level readings without the need for repeated skin punctures. They can reduce the incidence of both hyperglycemia and hypoglycemia, enhance quality of life, and improve glycemic control. Self-monitoring blood glucose devices are used by individuals who may not need continuous monitoring but still require regular checks of their glucose levels. These are suited for patients with both Type 1 and Type 2 diabetes, particularly those who manage their condition through diet, exercise, oral medication, or occasional insulin injections. SMBG devices provide a snapshot of the glucose level at the time of testing, requiring less commitment and expense compared to the more sophisticated CGMs. However, SMBGs rely on puncture tests, which can be less appealing to some users due to discomfort or inconvenience.

Testing Technology: Potential of electrode-type blood glucose monitors to be developed as portable and home-use devices

Electrode-type blood glucose monitors function by utilizing electrochemical reactions to measure glucose levels in the blood. A small blood sample is placed on a test strip, which contains an enzyme that reacts with glucose. The reaction produces a small electrical current that is measured by the electrodes, and the glucose level is then displayed on the monitor. Photoelectric blood glucose monitors work on the principle of photometry and uses a beam of light to measure the amount of glucose in the blood. The light interacts with the blood sample on the test strip, and the amount of light absorbed indicates the glucose concentration. Electrode-type monitors offer quick and highly accurate measurements, which makes them suitable for medical and emergency settings, as well as for diabetic patients who closely manage their condition. On the other hand, photoelectric monitors provide a non-invasive alternative that caters to those who seek comfort and potentially lower repetitive costs.

Application: Need for sophisticated CGMs with accuracy and constant monitoring for type-1 diabetes

Gestational diabetes mellitus (GDM) is characterized by glucose intolerance of varying severity and typically occurs during pregnancy. Blood glucose monitoring for GDM is critical to ensure the health of the mother and the developing fetus. Patients with GDM may have a specific need for monitoring tools with high accuracy and ease of use to manage glucose levels effectively, considering the temporary phase of their condition. Individuals with Type 1 Diabetes require lifelong insulin therapy and regular blood glucose monitoring. GDM requires continuous glucose monitoring systems (CGMs) that provide real-time readings and trend information, which can help in the tight management of their condition. Type 2 Diabetes, often related to lifestyle factors, requires personal blood glucose monitors for regular checks. Patients might prefer affordable and simple-to-use glucometers. Blood glucose monitors with connectivity features that can store data for long-term observation appeal to this segment. For gestational diabetes, the market emphasizes temporary monitoring solutions with advanced data management and sharing capabilities. In contrast, Type 1 Diabetes monitoring solutions prioritize accuracy and constant monitoring. Meanwhile, the market for Type 2 Diabetes focuses on cost-efficiency and ease of use, as patients often need to balance diabetes management with other life commitments.

End-User: Provision of blood glucose monitors that optimize clinical efficiency and patient throughput in hospitals

Home care pertains to blood glucose monitoring solutions used by individuals with diabetes or at risk of developing diabetes, primarily in a non-clinical setting. In the home care segment, users typically prefer compact, easy-to-use devices with minimal maintenance. Features such as connectivity to smartphones and seamless data transfer for remote patient monitoring are increasingly popular. Accuracy, affordability, and minimally invasive technology are also high on the preference list for home care users. Hospitals and clinics represent another major segment for blood glucose monitoring, where the emphasis is on precision, real-time monitoring, integration with hospital management systems, and the facilitation of comprehensive care for inpatients. These establishments require devices that can support a high volume of patients, offer robust connectivity for electronic health records (EHR) integration, and ensure precise, quick readings to inform immediate clinical decisions. High-quality, reliable, and easily sterilizable devices are preferred to prevent cross-contamination issues.

Regional Insights

In the Americas, blood glucose monitoring devices are widely used, owing to the increasing prevalence of diabetes, particularly in the United States, which has a mature market for diabetes care. The production of these systems in this region is characterized by high technological innovation, stringent regulatory oversight, and substantial investments in research and development. Major companies based in the Americas provide advanced monitoring systems, including continuous glucose monitoring (CGM) devices and flash glucose monitoring systems. On the other hand, in the Asia-Pacific (APAC) region, there is rapid growth in the blood glucose monitoring market, fueled by the rising diabetic population, growing healthcare awareness, and improving healthcare infrastructure, particularly in emerging economies such as China and India. Production in APAC tends to focus on cost-effectiveness and accessibility, with international companies expanding their footprint to capture the burgeoning demand. Western Europe shows a strong demand for innovative and non-invasive monitoring technologies similar to the Americas, while the Middle East and Africa are emerging markets with a focus on basic glucose monitoring systems due to cost constraints and varying levels of healthcare infrastructure. Companies in the EMEA region are working to strive to balance between introducing advanced products and catering to affordability in different parts of the region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Blood Glucose Monitoring Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Blood Glucose Monitoring Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Blood Glucose Monitoring Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AdvaCare Pharma, Advin Health Care, ARKRAY, Inc., Ascensia Diabetes Care Holdings AG by PHC Holdings Corporation, B. Braun Melsungen AG, BAYER AG, Becton, Dickinson and Company, Dexcom, Inc., F. Hoffmann-La Roche Ltd., GlySens Incorporated, I-SENS, Inc., Insulet Corporation, Johnson & Johnson Services, Inc., LifeScan IP Holding, LLC., Medtronic PLC, Medtrum Technologies Inc., Nemaura Medical Inc., Nipro Europe Group Companies, Nova Biomedical, Novo Nordisk A/s, NXP Semiconductors N.V., PHC Holding Corporation, Prodigy Diabetes Care LLC, Sanofi S.A., Senseonics Holdings Inc., Sinocare Inc., Teladoc Health, Inc., Terumo Corporation, and Ypsomed AG.

Market Segmentation & Coverage

This research report categorizes the Blood Glucose Monitoring Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Continuous Blood Glucose Monitors
      • Insulin Pumps
      • Sensors
      • Transmitter & Receiver
    • Self or One Time Monitors
      • Blood Glucose Meter
      • Lancets
      • Testing Strips
  • Testing Technology
    • Electrode Type Blood Glucose Monitor
    • Photoelectric Blood Glucose Monitor
  • Application
    • Gestational Diabetes
    • Type 1 Diabetes
    • Type 2 Diabetes
  • Distribution Channel
    • Offline
    • Online
  • End-User
    • Home Care
    • Hospital & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Blood Glucose Monitoring Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Blood Glucose Monitoring Market?

3. What are the technology trends and regulatory frameworks in the Blood Glucose Monitoring Market?

4. What is the market share of the leading vendors in the Blood Glucose Monitoring Market?

5. Which modes and strategic moves are suitable for entering the Blood Glucose Monitoring Market?

Product Code: MRR-957C47F90031

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of diabetes and improved awareness programs
      • 5.1.1.2. Increasing preference for non-invasive blood glucose monitoring technology
      • 5.1.1.3. Need for continuous blood glucose monitoring in-home care settings
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse recalls of blood glucose monitoring systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in design and capabilities of blood glucose monitoring systems
      • 5.1.3.2. Enhancements in the reimbursements for blood glucose monitoring
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity in the production and operation of blood glucose monitoring
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Provision of personalized guidance in self-monitoring blood glucose monitors
    • 5.2.2. Testing Technology: Potential of electrode-type blood glucose monitors to be developed as portable and home-use devices
    • 5.2.3. Application: Need for sophisticated CGMs with accuracy and constant monitoring for type-1 diabetes
    • 5.2.4. End-User: Provision of blood glucose monitors that optimize clinical efficiency and patient throughput in hospitals
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Blood Glucose Monitoring Market, by Product

  • 6.1. Introduction
  • 6.2. Continuous Blood Glucose Monitors
  • 6.3. Self or One Time Monitors

7. Blood Glucose Monitoring Market, by Testing Technology

  • 7.1. Introduction
  • 7.2. Electrode Type Blood Glucose Monitor
  • 7.3. Photoelectric Blood Glucose Monitor

8. Blood Glucose Monitoring Market, by Application

  • 8.1. Introduction
  • 8.2. Gestational Diabetes
  • 8.3. Type 1 Diabetes
  • 8.4. Type 2 Diabetes

9. Blood Glucose Monitoring Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Offline
  • 9.3. Online

10. Blood Glucose Monitoring Market, by End-User

  • 10.1. Introduction
  • 10.2. Home Care
  • 10.3. Hospital & Clinics

11. Americas Blood Glucose Monitoring Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Blood Glucose Monitoring Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Blood Glucose Monitoring Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Abbott Completes Acquisition Of Bigfoot Biomedical
    • 14.3.2. Dexcom Announces Novel Wearable For Managing Type 2 Diabetes - Without Insulin
    • 14.3.3. Astellas and Roche Diabetes Care Japan Ink Partnership Agreement To Develop And Commercialize Integrated Diabetes Self-Management Solution with BlueStar
  • 14.4. Strategy Analysis & Recommendation

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio
Product Code: MRR-957C47F90031

LIST OF FIGURES

  • FIGURE 1. BLOOD GLUCOSE MONITORING MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD GLUCOSE MONITORING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BLOOD GLUCOSE MONITORING MARKET DYNAMICS
  • FIGURE 7. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. BLOOD GLUCOSE MONITORING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. BLOOD GLUCOSE MONITORING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BLOOD GLUCOSE MONITORING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SENSORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SENSORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TRANSMITTER & RECEIVER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TRANSMITTER & RECEIVER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY BLOOD GLUCOSE METER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY BLOOD GLUCOSE METER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY LANCETS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY LANCETS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING STRIPS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING STRIPS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY ELECTRODE TYPE BLOOD GLUCOSE MONITOR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY ELECTRODE TYPE BLOOD GLUCOSE MONITOR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PHOTOELECTRIC BLOOD GLUCOSE MONITOR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PHOTOELECTRIC BLOOD GLUCOSE MONITOR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY OFFLINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY ONLINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY ONLINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOME CARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 91. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 92. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 96. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 97. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 98. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 103. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 104. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 107. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 108. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 109. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 110. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 111. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 112. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 115. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 116. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 117. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 118. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 119. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 120. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 121. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 122. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 123. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 124. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 125. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 126. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 129. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 130. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 131. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 132. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 133. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 134. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 135. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 138. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 139. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 140. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 141. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 142. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 160. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 162. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 163. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 164. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 165. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 166. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 167. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 170. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 171. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 172. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 173. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 174. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 175. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 176. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 177. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 178. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 179. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 180. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 181. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 182. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 183. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 184. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 185. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 188. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 189. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 190. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 191. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 192. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 193. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 194. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 195. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 196. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 197. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 198. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 199. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 200. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 201. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 202. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 203. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 204. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 205. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 206. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 207. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 208. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 209. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 210. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 211. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 212. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 213. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 214. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 215. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 216. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 217. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 218. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 219. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 220. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 221. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 222. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 223. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 224. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 225. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 226. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 227. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 228. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 229. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 230. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 231. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 232. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 233. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 234. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 235. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 236. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 237. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 238. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 239. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 240. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 241. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 242. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 243. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 244. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 245. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 246. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 247. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 248. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 249. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 250. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 251. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 252. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 253. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 254. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 255. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 256. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 257. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 258. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 259. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 260. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 261. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 262. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 263. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 264. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 265. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 268. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 269. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 270. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 271. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 272. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 273. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 274. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 275. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 276. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 277. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 278. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 279. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 280. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 281. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 282. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 283. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 284. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 285. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 286. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 287. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 288. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 289. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 290. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 291. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 292. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 293. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 294. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 295. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 296. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 297. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 298. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 299. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 300. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 301. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 302. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 303. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 304. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 305. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 306. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 307. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 308. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 309. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 310. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 311. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 312. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 313. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 314. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!